Tabuk Pharmaceuticals Manufacturing Company-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Tabuk Pharmaceuticals Manufacturing Company - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013212
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:サウジアラビア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tabuk Pharmaceuticals Manufacturing Company (Tabuk), a subsidiary of Astra Industrial Group is a drug company that develops, manufactures and markets branded generic pharmaceuticals and under-licensed products . The company offers products in various therapeutic areas including alimentary tract and metabolism, antineoplastic and immuno-modulators, blood and blood forming organs, cardiovascular system, systemic anti infective, dermatologicals, genito-urinary system and sex hormones, multivitamin, musculo skeletal, nervous system, parasitology, respiratory system and others. It collaborates with other pharmaceutical companies to enhance its portfolio of medicines. The company has a presence in Middle East and North Africa regions. Tabuk is headquartered in Riyadh, Saudi Arabia.

Tabuk Pharmaceuticals Manufacturing Company – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Tabuk Pharma Enters into Distribution Agreement with Genetic 10
Licensing Agreements 11
Tabuk Pharma Enters into Licensing Agreement with Selectchemie 11
Tabuk Pharma Enters into Licensing Agreement with Dong-A ST for Zydena 12
Innovus Pharma Entes into Licensing Agreement with Tabuk Pharma 13
Tabuk Pharma Enters into Licensing Agreement with Aenova 14
Tabuk Pharma Enters into Licensing Agreement with Pfizer 15
Asset Transactions 16
Acino Pharma Acquires Three Products from Tabuk Pharma 16
Tabuk Pharmaceuticals Manufacturing Company – Key Competitors 17
Tabuk Pharmaceuticals Manufacturing Company – Key Employees 18
Tabuk Pharmaceuticals Manufacturing Company – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Key Facts 2
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Tabuk Pharmaceuticals Manufacturing Company, Deals By Therapy Area, 2011 to YTD 2017 8
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Tabuk Pharma Enters into Distribution Agreement with Genetic 10
Tabuk Pharma Enters into Licensing Agreement with Selectchemie 11
Tabuk Pharma Enters into Licensing Agreement with Dong-A ST for Zydena 12
Innovus Pharma Entes into Licensing Agreement with Tabuk Pharma 13
Tabuk Pharma Enters into Licensing Agreement with Aenova 14
Tabuk Pharma Enters into Licensing Agreement with Pfizer 15
Acino Pharma Acquires Three Products from Tabuk Pharma 16
Tabuk Pharmaceuticals Manufacturing Company, Key Competitors 17
Tabuk Pharmaceuticals Manufacturing Company, Key Employees 18
Tabuk Pharmaceuticals Manufacturing Company, Other Locations 19

★海外企業調査レポート[Tabuk Pharmaceuticals Manufacturing Company-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shelby Energy Cooperative, Inc.:企業の戦略的SWOT分析
    Shelby Energy Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Insulet Corp (PODD)-製薬・医療分野:企業M&A・提携分析
    Summary Insulet Corp (Insulet) is a medical device company that develops, manufactures and distributes OmniPod insulin management system, an insulin infusion system for diabetic patients. OmniPod insulin management system consists of OmniPod, a disposable insulin infusion device and the Personal Dia …
  • McEwen Mining Inc.:企業の戦略・SWOT・財務情報
    McEwen Mining Inc. - Strategy, SWOT and Corporate Finance Report Summary McEwen Mining Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Kracie Holdings, Ltd.:戦略・SWOT・企業財務分析
    Kracie Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kracie Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Lite-On Technology Corp (2301):企業の財務・戦略的SWOT分析
    Lite-On Technology Corp (2301) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Intec Pharma ltd (NTEC):企業の財務・戦略的SWOT分析
    Summary Intec Pharma Ltd (Intec Pharma) is a biopharmaceutical company that offers delivery solutions for drugs. The company’s pipeline products include drug indications for Parkinson’s disease, insomnia and other diseases. Its proprietary gastro retentive formulation, offers a drug delivery solutio …
  • Nachi-Fujikoshi Corp (6474):企業の財務・戦略的SWOT分析
    Nachi-Fujikoshi Corp (6474) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Teijin Ltd (3401)-医療機器分野:企業M&A・提携分析
    Summary Teijin Ltd (Teijin) is a technology driven holding company offering solutions in the areas of information and electronics, healthcare, environment and energy and safety and protection. It focuses on the manufacture and sale of aramid fiber, carbon fiber products, synthetic fiber, films, poly …
  • MOL Hungarian Oil and Gas PLC (MOL)-エネルギー分野:企業M&A・提携分析
    Summary MOL Hungarian Oil and Gas Public Limited Company (MOL) is an integrated oil and gas company. It explores develops and produces crude oil, natural gas. It conducts refining, transportation and storage of crude oil; wholesale and retail marketing of crude oil products, production and sale of p …
  • Gebr. Heinemann SE & Co. KG:企業の戦略・SWOT・財務情報
    Gebr. Heinemann SE & Co. KG - Strategy, SWOT and Corporate Finance Report Summary Gebr. Heinemann SE & Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Cathay United Bank Co Ltd:企業の戦略・SWOT・財務情報
    Cathay United Bank Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Cathay United Bank Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Dai-ichi Life Holdings, Inc.:企業の戦略・SWOT・財務情報
    Dai-ichi Life Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dai-ichi Life Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Hoag Hospital Foundation:企業の戦略的SWOT分析
    Hoag Hospital Foundation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Inhibitor Therapeutics Inc (INTI):企業の財務・戦略的SWOT分析
    Inhibitor Therapeutics Inc (INTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • AGL Energy Ltd (AGL):石油・ガス:M&Aディール及び事業提携情報
    Summary AGL Energy Limited (AGL) is an integrated energy company that owns, operates and develops energy assets and provides natural gas, electricity, solar photovoltaic solutions and related products and services. The company’s power generation portfolio includes coal, gas, hydro, wind, solar, land …
  • Development Bank of Southern Africa:電力:M&Aディール及び事業提携情報
    Summary Development Bank of Southern Africa (DBSA) offers various leading and infrastructure development financial services. Its service offering includes debt limited non-recourse lending, mezzanine finance, and promotion of inter-regional integration and co-operation. It offers implementation serv …
  • Southern California Edison Co:企業の発電所・SWOT分析2018
    Southern California Edison Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Hobby Lobby Stores Inc:戦略・SWOT・企業財務分析
    Hobby Lobby Stores Inc - Strategy, SWOT and Corporate Finance Report Summary Hobby Lobby Stores Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Carl Zeiss AG:企業の戦略的SWOT分析
    Carl Zeiss AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Inretail Peru Corp.:企業の戦略的SWOT分析
    Inretail Peru Corp. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆